It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
WHO warns against COVID-19 complacency after Moderna vaccine news

World / Science & Health Nov 17, 2020

WHO warns against COVID-19 complacency after Moderna vaccine news

"Right now we are extremely concerned by the surge in cases we are seeing in some countries," WHO director-general Tedros Adhanom Ghebreyesus told a news briefing.

How the Moderna and Pfizer coronavirus vaccines stack up

World / Science & Health Nov 17, 2020

How the Moderna and Pfizer coronavirus vaccines stack up

by James Paton

The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.

Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection

World Nov 16, 2020

Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection

A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.

China under pressure to reveal vaccine data after Pfizer success

Asia Pacific Nov 13, 2020

China under pressure to reveal vaccine data after Pfizer success

While Beijing has hailed the progress on its own own COVID-19 vaccines, it has so far yet to back this up with evidence.

Moderna COVID-19 vaccine trial reaches key goal to gauge merit

World / Science & Health Nov 12, 2020

Moderna COVID-19 vaccine trial reaches key goal to gauge merit

The bet among top experts in the field is that Moderna’s therapy will likely prove to be highly effective.

Russia says its Sputnik V COVID-19 vaccine is 92% effective

World / Science & Health Nov 12, 2020

Russia says its Sputnik V COVID-19 vaccine is 92% effective

Experts welcomed the news but warned that the results were only based on a small number of trial volunteers who had contracted COVID-19.

Brazil says Chinese vaccine trial can resume after suspension

World / Science & Health Nov 12, 2020

Brazil says Chinese vaccine trial can resume after suspension

Brazil health regulator Anvisa on Wednesday allowed resumption of late-stage Brazilian clinical trials for China's Sinovac COVID-19 vaccine, which had been suspended due to a study subject's death that was registered in Sao Paulo as a suicide. Brazilian medical institute Butantan said in a statement ...

Brazil halts trial of Chinese vaccine. But was science or politics to blame?

World Nov 11, 2020

Brazil halts trial of Chinese vaccine. But was science or politics to blame?

by Sui-lee Wee and Ernesto Londono

Brazil's health regulator provided little information on its decision to suspend the trial, including whether a reported adverse reaction was related to the vaccine.

Why Pfizer’s vaccine won't be at the local pharmacy anytime soon

World / Science & Health | FOCUS Nov 10, 2020

Why Pfizer’s vaccine won't be at the local pharmacy anytime soon

by Carl O'Donnell

The vaccine's complex and supercold storage requirements are an obstacle for even the most sophisticated hospitals and may impact when and where it is available.

China vaccine trial halted in Brazil after serious adverse event

World / Science & Health Nov 10, 2020

China vaccine trial halted in Brazil after serious adverse event

The final-stage trial of a Chinese front-runner vaccine candidate has been halted in Brazil due to a serious adverse event, the first time that any of the Asian nation’s rapidly developed COVID-19 shots have met with such a setback. Testing of Sinovac Biotech Ltd.’s vaccine, ...

Pfizer's COVID-19 vaccine trial success signals breakthrough in pandemic battle

World / Science & Health Nov 10, 2020

Pfizer's COVID-19 vaccine trial success signals breakthrough in pandemic battle

The vaccine candidate is more than 90% effective based on initial trial results, the drugmaker said Monday.

The potential for a policy failure on vaccines is huge

Commentary / World Nov 7, 2020

The potential for a policy failure on vaccines is huge

by Ferdinando Giugliano

Leaders must make decisions about who will get a coronavirus shot first and provide adequate explanations to those denied the vaccine.

« 1 … 26 27 28 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times